Auffarth Gerd

CIK 00016498672 companiesDUBLIN 2, L2

SEC Profile

Transactions

Companies

Filings

CIK

0001649867

Recent Transactions

19 trades

Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-03+12,082→ 12,082 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-01+56,636→ 56,636 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-01+29,493→ 29,493 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-03-07+94,441→ 94,441 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2023-10-04+210,225→ 210,225 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2023-03-29+41,065→ 41,065 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2022-10-05+42,239→ 42,239 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2022-03-23+21,878→ 21,878 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2021-10-05+25,245→ 25,245 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2021-03-24+20,873→ 20,873 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-10-05$0.51/sh+85,586→ 85,586 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-07-17+125,000→ 125,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-07-01$0.99/sh+19,874→ 19,874 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-04-20+25,000→ 25,000 total
Award
Presbia PLC
Stock Option (right to buy)
2018-12-17+81,743→ 81,743 total
Award
Presbia PLC
Stock Option (right to buy)
2018-07-18+67,981→ 67,981 total
Award
Presbia PLC
Ordinary Shares
2017-03-13+12,738→ 38,464 total
Exercise of In-Money
Presbia PLC
Ordinary Shares
2017-03-08$3.00/sh+6,460→ 25,726 total
Exercise of In-Money
Presbia PLC
Subscription Rights (right to buy)
2017-03-08−19,269→ 0 total

Companies

Recent Filings

Address

C/O PRESBIA PLC 120/121 BAGGOT STREET LOWER

DUBLIN 2, L2, 00000

View on SEC.gov